Andrew Jess Dannenberg

Andrew Jess Dannenberg (born 17 February 1956) is a U.S. physician and researcher, currently Henry R. Erle, M.D. - Roberts Family Professor of Medicine at Weill Medical College/M.D. Anderson Cancer Center. He additionally holds the positions there of Professor of Medicine in Cardiothoracic Surgery and Director of Cancer Prevention. He received a B.s. from Tufts University in 1978 and a M.D. from Washington University School of Medicine in 1982.

Contents

Honors

Publications

His current work deals with the role of cyclooxygenase-2 (COX-2) in cancer.,,[2][3][4] He has previously been one of the three lead investigators of a major study on the role of aspirin in the prevention of breast cancer.[5]

Journals

According to Web of Science, he has published over 200 peer-reviewed articles, of which 27 have cited over 100 times. The most cited are:

Editor

References

  1. ^ http://www.aacr.org/home/scientists/scientific-achievement-awards/prevent-cancer-award.aspx
  2. ^ " COX-2 Inhibitors for Cancer Prevention & Treatment: Research Roundup: " by Lindsey, Heather Oncology Times
  3. ^ " COX-2 Inhibitors: Cancer Trials Test New Uses for Pain Drug" by Jennifer Michalowski Journal of the National Cancer Institute 24(4)April 2002p 52-54
  4. ^ "Researchers Plan To Continue To Study COX-2 Inhibitors in Cancer Treatment and Prevention" by Cori Vanchieri. JNCI Spectrum (with portrait)
  5. ^ "Women who regularly take aspirin at lower risk of breast cancer" Women's Health News Monday, 31-May-2004

External links